pre-IPO PHARMA

COMPANY OVERVIEW

Adgero Biopharmaceuticals, Inc. is a privately-held biopharmaceutical company focused on building a robust pipeline by advancing its proprietary late stage photodynamic therapy (PDT) platform with broad utility for the treatment of unmet needs in cancer.


LOCATION

  • Princeton, NJ, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    http://www.adgerobiopharm.com/


    CAREER WEBSITE

    http://www.adgerobiopharm.com/about/careers


    SOCIAL MEDIA


    INVESTORS

    shanghai-fudan-zhangjiang-bio-pharmaceutical


    PRESS RELEASES


    Aug 20, 2020

    Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Announces Completion of Merger with Adgero Biopharmaceuticals and Closing of $19.6 Million Private Placement Priced At-The-Market


    Jun 10, 2020

    DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology Pipeline


    For More Press Releases


    Google Analytics Alternative